Research indicates that Akt1 is capable of regulating Slc2a2 transcription in liver tissues, strengthening the liver’s capacity to uptake glucose from the circulation, facilitating cellular energy metabolism, and optimizing glucose utilization efficiency, consequently diminishing hyperglycemia [33]. This evidence concerns the gene SLC2A2 and Hyperglycemia.